L-Methionine-(S,R)-Sulfoximine (MSX; MSO), a highly specific and irreversible inhibitor of Glutamine synthetase (GS), is also a potent convulsant which metabolically and morphologically primarily affects astroglia. L-Methionine-(S,R)-Sulfoximine has been employed to inhibit the Gln-dependent ammonia-stimulated neuronal toxicity in vitro, potentiating Gln deficit-dependent depression. L-Methionine-(S,R)-Sulfoximine tremendously increases the rate of release of fixed nitrogen in cyanobacteria. L-Methionine-(S,R)-Sulfoximine is a promising candidate for research in biofertilizers and convulsive seizures (CS).